Latest Commercial Scale Up News

Peninsula Energy expects to book an approximately US$50 million non-cash impairment against legacy assets at its Lance uranium project in Wyoming. The charge removes value from Mine Units 1, 2 and 3 as the company concentrates capital and technical resources on Mine Unit 4 and future development.

Advanced Engineered Materials is forecasting a sharp lift in second-half sales as its Quebec high-purity alumina operation moves from qualification work towards commercial production. The larger prize is a possible 6,000-tonne-per-year expansion, but that plan still depends on feasibility, financing and final investment approval.

BCAL Diagnostics has begun introducing ClearNote Health’s Avantect Multi-Cancer blood test in Australia, starting with Sydney and Melbourne. The test reported 56.2% sensitivity and 98.4% specificity in a case-control validation study, but the company says a negative result does not rule out cancer.

Firebird Metals has prepared the first manganese feedstock for its Australian Demonstration Plant, marking a practical step towards testing its integrated pathway from Western Australian ore to battery materials. Equipment remains scheduled to arrive in October, with commissioning targeted for the fourth quarter of 2026.

Black Canyon has spent the 2026 financial year moving Wandanya from discovery towards resource definition, backed by 17,200 metres of drilling and encouraging manganese beneficiation results. The exploration company ended the year with $7.77 million in cash and no debt, but remains reliant on future funding before any development decision can be made.

Papyrus Australia moved its banana-fibre technology into early commercialisation during FY26, signing an estimated $4.2 million TBS supply contract and delivering commercial-scale samples. But the company ended the year with $257,077 cash, negative equity and an auditor-flagged material uncertainty over its ability to continue as a going concern.

Magnum Mining has completed a 10,000-metre auger programme at its Piracanjuba North ionic adsorption clay rare earths project in Brazil, shifting its focus to a 32.5km² plateau zone. The company is targeting a maiden JORC 2012 Mineral Resource Estimate in November, but the project remains at an early exploration stage with no declared resource or reserve.

Zeotech Limited (ASX:ZEO) is moving Toondoon toward its first direct-shipping kaolin export after securing a potential A$200 million offtake agreement, while AusPozz™ and zeoteCH₄® produce encouraging trial results. The progress came alongside an A$8.15 million FY26 loss, negative operating cash flow and an acknowledgement that further funding may be required.

OD6 Metals has transformed its portfolio with the completed acquisition of Nevada’s Quinn Fluorspar Project, but the strategic expansion comes alongside a larger loss, ongoing funding needs and substantial permitting risk. The company is now targeting drilling and a maiden resource at Quinn while advancing laboratory-scale rare earth processing work at Splinter Rock.

Telix will acquire ITM in a proposed US$1.65 billion deal that combines a commercial radioisotope supplier with Telix’s precision medicine and therapeutic pipeline. The transaction could give Telix greater supply-chain control and entry into a validated cancer treatment market, but it also brings dilution, integration risk and an unresolved FDA pathway for ITM-11.

Vulcan Energy has started commercial-scale production in Germany of VULSORB, the proprietary adsorbent at the centre of its planned direct lithium extraction process. The material will supply first-fill volumes for Project Lionheart, although lithium production remains targeted for the second half of 2028.

FireFly Metals has turned a year of aggressive drilling into a substantially larger, higher-confidence Green Bay resource, backed by an August PEA and fresh funding. The next test is execution: feasibility, permits, construction decisions and the capital required to build a mine.